Study of Cadonilimab Combined With Bevacizumab and Standard Chemotherapy as First Line Therapy in Unresectable Pleural Mesothelioma
Clinical trial NCT05930665 · UNKNOWN
Trial details
- NCT number
- NCT05930665
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2025-07-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.